“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Did cops need to kill a 95-year-old veteran with a Taser, riot shield and shotgun?
San Diego Mayor Bob Filner Urges ‘Jury Nullification’ In Medical Pot Dispensary Case
Judge rules Portland teen not guilty after phone video contradicts police
Police ignore Taser heart attack risk and keep firing at suspects’ chests
Comcast unveils 2-gigabit fiber internet service for $300/mo
Pre-election Bin Laden raid film will feature extra Obama footage
High school students suspended for possession of energy mints
Twitter report: U.S. leads the world in demands for user information
Embargoed EU Goods Actively Re-Imported to Russia via Belarus
Dying Organs Restored To Life With Mitochondria Injections
Taiwan central bank 'keeping close tabs' on Bitcoin
Germany drops fracking law until after September's election
Santa Ana Police Officer Shot, Killed Unarmed Homeless Man
‘Creepy’ camera irks Platte City family
Police, Looking for 6 Foot 270 lb Black Man, Shoot 2 Asian Women Delivering Newspapers